way 100135 has been researched along with pnu-282987 in 1 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (pnu-282987) | Trials (pnu-282987) | Recent Studies (post-2010) (pnu-282987) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 146 | 0 | 123 |
| Protein | Taxonomy | way 100135 (IC50) | pnu-282987 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.541 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.541 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pandya, AA; Yakel, JL | 1 |
1 other study(ies) available for way 100135 and pnu-282987
| Article | Year |
|---|---|
Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anxiety; Behavior, Animal; Benzamides; Bridged Bicyclo Compounds; Drug Interactions; Isoxazoles; Learning; Male; Memory Disorders; Nicotinic Agonists; Nicotinic Antagonists; Phenylurea Compounds; Piperazines; Rats; Scopolamine; Serotonin 5-HT1 Receptor Antagonists | 2013 |